Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1077 | 1148 | 1132 | 1313 | 1781 | 3511 |
Fund Return | 7.74% | 14.76% | 13.23% | 9.5% | 12.24% | 13.38% |
Place in category | 116 | 117 | 61 | 116 | 21 | 22 |
% in Category | 12 | 11 | 7 | 26 | 6 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology Fund Ag | 18.77M | 18.38 | 12.48 | 18.99 | ||
S Horizon Global Technology Fund 1g | 2.58M | 18.62 | 13.46 | 20.03 | ||
S Horizon Global Technology Fund Hg | 6.25M | 13.85 | 12.16 | 19.04 | ||
Opportunities Fund P Acc | 484.64K | 6.34 | 10.52 | 9.45 | ||
Opportunities Fund I Inc | 41.65M | 6.25 | 10.20 | 9.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiG | 2.42B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 115.5M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.51B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Acc | 257.12K | 8.14 | 10.01 | 11.74 | ||
Pharmaceuticals Index Trust F Dist | 877.21Array | 8.28 | 10.01 | 11.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.66 | 742.99 | +1.59% | |
UnitedHealth | US91324P1021 | 5.99 | 489.15 | -0.42% | |
Novo Nordisk B | DK0062498333 | 4.82 | 891.3 | +1.83% | |
Merck&Co | US58933Y1055 | 3.57 | 127.07 | +0.10% | |
AstraZeneca | GB0009895292 | 3.57 | 11,268.0 | +0.16% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Sell | Neutral | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review